RBC Capital Upgrades Sage Therapeutics (SAGE) to Outperform
Tweet Send to a Friend
(Updated - March 13, 2023 6:14 AM EDT)
RBC Capital analyst Brian Abrahams upgraded Sage Therapeutics (NASDAQ: SAGE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams upgraded Sage Therapeutics (NASDAQ: SAGE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
